Gastrografin for Malignant Bowel Obstruction
Ontology highlight
ABSTRACT: Interventions: Treatment Arm will receive both:
a. Standard palliative management of malignant bowel
obstruction and
b. One time oral dose of 100ml of sodium diatrozoate,
meglumine datrozoate solution (Gastrografin)
Primary outcome(s): Time from administration of gastrografin to resolution of malignant bowel obstruction signified by passage of flatus/stool.[30 minutes post intervention
6 hours post intervention
12 hours post intervention
24 hours post intervention
2 days post intervention
3 days post intervention]
Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy
DISEASE(S): Oral And Gastrointestinal-other Diseases Of The Mouth, Teeth, Oesophagus, Digestive System Including Liver And Colon,Cancer-bowel-small Bowel (duodenum And Ileum),Malignant Bowel Obstruction
PROVIDER: 2456399 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA